With cardiovascular diseases on the rise, new and innovative treatment solutions are the need of the hour, say experts at Aster DM Healthcare’s cardiovascular conference in UAE
The international conference, accredited by DHA, saw participation from 200 leading international cardiologists and cardiothoracic surgeons who introduced new guidelines on heart failure management, onco-cardiology, cardiac therapeutics and hybrid treatment.
With an aim to introduce doctors from the region, to the latest techniques in the field of cardiovascular treatment which will help them optimize patient solutions, Aster DM Healthcare brought together international experts from Aster Medcity, Aster MIMS, Aster CMI, Aster Jubilee Clinic- Dubai, Michigan University-USA and the UAE, at the international CME conference entitled ‘Newer Therapeutic options for Cardiovascular Diseases in 2016′. The experts highlighted that, new treatment or surgery mechanisms like onco-cardiology, minimal invasive surgery, hybrid treatment of aneurysm, novel techniques in lowering cholesterol or cardiac therapy, can go a long-way in saving lives and improving treatment options for patients.
“Sedentary life-style in UAE, smoking habits, unhealthy eating, obesity and diabetes, are considered as key risk factors for heart diseases. We often come across patients who have been suffering from high-blood pressure or hypertension for years without any visible symptoms, deterring diagnosis. Prolonged undetected high blood pressure, cholesterol and hypertension can lead to complications associated with cardiovascular diseases like heart attack or failure, heart valve blockage, arrhythmia (abnormal rhythm of the heart) or stroke which can be life-threatening,” said Dr. T.M. Jaison, Lead Senior Specialist Cardiologist, Aster Jubilee Clinic Dubai.
Dr. Azad Moopen, Chairman and Managing Director of Aster DM Healthcare said, “One of our constant efforts at Aster DM Healthcare is to deliver quality outcomes for patients, by enhancing the skills of our doctors and experts by introducing them to the latest scientific development in a particular therapeutic area. With this year’s conference on cardiovascular diseases, we assure our patients of well-informed doctors and healthcare practitioners who will deliver best practices for their care and well-being.”
Through series of lectures, workshops, panel discussions and interactive sessions the experts debated the latest advances in treatment and surgery techniques. The meeting provided the opportunity to interact with leading experts in the field and saw immense enthusiasm to know more through engaged discussions, thought-provoking questions and answers.
The Dubai Health Authority (DHA) accredited the conference with 5.25 CME (Continuing Medical Education) hours. Some of the topics covered were: Heart Failure Treatment Guidelines 2016 (Dr. Anil Kumar- Lead Senior Consultant & Interventional Cardiologist, Aster Medcity); Percutaneous closure of VSD (Dr. Anil S.R, Senior consultant, Paediatric Cardiologist, Aster Medcity); Hybrid Treatment of Aneurysm (Manoj Nair, Senior Consultant, Cardiovascular Thoracic Surgery, Aster Medcity); Comprehensive management of Cardiac Arrhythmias (Dr. Praveen, Consultant Cardiologist & Cardiac Electrophysiologist); Onco- cardiology: the other face of cancer (Dr. Rakesh Gopal, HOD, Department of Cardiology, Aster MIMS); Minimally Invasive Cardiac Surgery (Dr. Mahadev Dixit, Senior Consultant, Cardiac Surgery & Chief of Cardiac Sciences, Aster CMI); Novel Mechanisms to lower cholesterol (Dr. T.M. Jaison, Lead Senior Specialist Cardiologist, Aster Jubilee Clinic, Dubai); ECG Directed Cardiac Therapeutics in the Modern Era (Dr. Anil Kumar and Dr. Praveen Sreekumar).